Neuronetics (STIM) News Today $0.86 -0.06 (-6.52%) (As of 10/10/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 Time Period Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder MeetingsOctober 4, 2024 | prnewswire.comBrainsWay: More Cash, More UncertaintyOctober 1, 2024 | seekingalpha.comNeuronetics Expands TMS Access for Adolescents with DepressionSeptember 27, 2024 | msn.comHealth Care Service Corporation Adds First-Line TMS Coverage for AdolescentsSeptember 25, 2024 | globenewswire.comNeuronetics Expands TMS Coverage, Enhancing Access for MDD TreatmentSeptember 21, 2024 | msn.comNeuronetics Enhances NeuroStar Therapy with New FeaturesSeptember 19, 2024 | msn.comExpanded Health Policies Enhance TMS Therapy Access for Adolescents and AdultsSeptember 19, 2024 | globenewswire.comNeuroStar® Releases Software Upgrades to Elevate Patient CareSeptember 16, 2024 | globenewswire.comRobert Cascella Purchases 100,000 Shares of Neuronetics, Inc. (NASDAQ:STIM) StockSeptember 14, 2024 | insidertrades.comInsider Buying: Neuronetics, Inc. (NASDAQ:STIM) Director Buys 25,000 Shares of StockSeptember 7, 2024 | insidertrades.comNeuronetics’ Breakthrough: How NeuroStar Therapy Is Transforming Lives Amid Rising Suicide RatesSeptember 5, 2024 | msn.comNeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful StoriesSeptember 3, 2024 | globenewswire.comNeuronetics, Inc. (NASDAQ:STIM) Director Glenn P. Muir Purchases 12,776 SharesAugust 31, 2024 | insidertrades.comNeuronetics Celebrates Two Years of NeuroStar UniversityAugust 21, 2024 | msn.comNeuronetics, Inc. (NASDAQ:STIM) Director Robert Cascella Buys 35,000 SharesAugust 20, 2024 | insidertrades.comRobert Cascella Buys 35,000 Shares of Neuronetics, Inc. (NASDAQ:STIM) StockAugust 17, 2024 | insidertrades.comWilliam Blair Downgrades Neuronetics (STIM)August 14, 2024 | msn.comNeuronetics, Inc. (NASDAQ:STIM) Q2 2024 Earnings Call TranscriptAugust 14, 2024 | msn.comNeuronetics Acquires Greenbrook TMS, Enhancing Mental Health Care DeliveryAugust 14, 2024 | msn.comNeuronetics, Inc. (STIM) Q2 2024 Earnings Call TranscriptAugust 12, 2024 | seekingalpha.comNeuronetics, Inc. Q2 Loss Increases, Misses EstimatesAugust 12, 2024 | markets.businessinsider.comNeuronetics agrees to merge with Canadian company; stock price plummetsAugust 12, 2024 | bizjournals.comSTIM Stock Earnings: Neuronetics Misses EPS, Misses Revenue for Q2 2024August 12, 2024 | msn.comNeuronetics and Greenbrook TMS Announce Definitive Agreement to MergeAugust 12, 2024 | globenewswire.comNeuronetics Reports Record Second Quarter 2024 Financial and Operating ResultsAugust 12, 2024 | globenewswire.comNeuronetics earnings: here's what Wall Street expectsAugust 12, 2024 | markets.businessinsider.comNeuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)August 5, 2024 | globenewswire.comNeuronetics (STIM) Scheduled to Post Earnings on MondayNeuronetics (NASDAQ:STIM) will be releasing earnings before the market opens on Monday, August 12, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=614214)August 5, 2024 | marketbeat.comNeuronetics to Present at Canaccord Genuity Growth ConferenceAugust 2, 2024 | msn.comNeuroStar Partners With This Is My Brave to Recognize Teen Mental Health MonthAugust 1, 2024 | globenewswire.comNeuronetics to Announce Q2 Financial Results and Host Conference CallJuly 31, 2024 | msn.comNeuronetics to Present at the Canaccord Genuity 44th Annual Growth ConferenceJuly 31, 2024 | finance.yahoo.comChester County medical technology company enters into $90M debt dealJuly 30, 2024 | bizjournals.comNeuronetics Announces the Closing of up to $90 Million Senior Secured Credit Facility with Perceptive AdvisorsJuly 30, 2024 | globenewswire.comNeuronetics (NASDAQ:STIM) shareholders have endured a 85% loss from investing in the stock three years agoJuly 29, 2024 | finance.yahoo.comNeuronetics to Report Second Quarter 2024 Financial and Operating Results and Host Conference CallJuly 29, 2024 | globenewswire.comNeuronetics, Inc. (NASDAQ:STIM) CEO Sells $45,907.80 in StockJuly 23, 2024 | insidertrades.comBrainsWay: An Interesting Niche ConcernJuly 22, 2024 | seekingalpha.comAetna Policy Update Expands TMS Availability for Adolescents With DepressionJuly 22, 2024 | globenewswire.comInsider Selling: Neuronetics, Inc. (NASDAQ:STIM) CEO Sells 12,075 Shares of StockJuly 19, 2024 | insidertrades.comShort Interest in Neuronetics, Inc. (NASDAQ:STIM) Increases By 31.6%Neuronetics, Inc. (NASDAQ:STIM - Get Free Report) was the target of a significant growth in short interest during the month of June. As of June 30th, there was short interest totalling 119,100 shares, a growth of 31.6% from the June 15th total of 90,500 shares. Based on an average trading volume of 143,600 shares, the short-interest ratio is currently 0.8 days.July 13, 2024 | marketbeat.comCalifornia Medicaid Adds TMS Access for 14.8 Million Adolescents and AdultsJuly 11, 2024 | globenewswire.comBlueCross BlueShield MI and Cambia Health Solutions Expand TMS Access for Depressed AdolescentsJuly 10, 2024 | globenewswire.comNeuronetics (NASDAQ:STIM) Trading Up 1.7%Neuronetics (NASDAQ:STIM) Trading 1.7% HigherJuly 5, 2024 | marketbeat.comNeuroStar® Launches Better Me Provider Program NationwideJuly 1, 2024 | globenewswire.comNeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual MeetingJune 13, 2024 | globenewswire.comNeuronetics, Inc. (NASDAQ:STIM) Short Interest Up 436.7% in MayNeuronetics, Inc. (NASDAQ:STIM - Get Free Report) saw a significant growth in short interest in May. As of May 31st, there was short interest totalling 96,600 shares, a growth of 436.7% from the May 15th total of 18,000 shares. Based on an average daily volume of 164,400 shares, the days-to-cover ratio is currently 0.6 days.June 12, 2024 | marketbeat.comRobert Cascella Purchases 50,000 Shares of Neuronetics, Inc. (NASDAQ:STIM) StockJune 7, 2024 | insidertrades.comInsider Buying: Neuronetics, Inc. (NASDAQ:STIM) Director Purchases 50,000 Shares of StockNeuronetics, Inc. (NASDAQ:STIM - Get Free Report) Director Robert Cascella acquired 50,000 shares of the firm's stock in a transaction that occurred on Thursday, June 6th. The stock was acquired at an average cost of $2.05 per share, with a total value of $102,500.00. Following the completion of the acquisition, the director now directly owns 244,098 shares in the company, valued at $500,400.90. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.June 6, 2024 | marketbeat.comNeuronetics, Inc. (NASDAQ:STIM) Sees Significant Decrease in Short InterestNeuronetics, Inc. (NASDAQ:STIM - Get Free Report) was the target of a significant decline in short interest in May. As of May 15th, there was short interest totalling 18,000 shares, a decline of 69.1% from the April 30th total of 58,300 shares. Based on an average trading volume of 176,600 shares, the short-interest ratio is currently 0.1 days.May 28, 2024 | marketbeat.com Get Neuronetics News Delivered to You Automatically Sign up to receive the latest news and ratings for STIM and its competitors with MarketBeat's FREE daily newsletter. Email Address Musk’s new company could top a trillion? (Ad)The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840. Click here to see the details because there’s not much time to prepare. STIM Media Mentions By Week STIM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. STIM News Sentiment▼0.940.72▲Average Medical News Sentiment STIM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. STIM Articles This Week▼52▲STIM Articles Average Week Get Neuronetics News Delivered to You Automatically Sign up to receive the latest news and ratings for STIM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TTOO News Today PAVM News Today FONR News Today EDAP News Today PDEX News Today MGRM News Today HYPR News Today MODD News Today NTRB News Today APT News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:STIM) was last updated on 10/11/2024 by MarketBeat.com Staff From Our PartnersWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | SponsoredBigger Than Nvidia?Bigger Than Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the n...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neuronetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neuronetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.